Compare LNTH & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | PSN |
|---|---|---|
| Founded | 1956 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 9.2B |
| IPO Year | 2015 | 2019 |
| Metric | LNTH | PSN |
|---|---|---|
| Price | $66.68 | $62.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 15 |
| Target Price | $78.00 | ★ $85.29 |
| AVG Volume (30 Days) | 1.2M | ★ 2.2M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.02 |
| EPS | ★ 2.39 | 2.17 |
| Revenue | $1,525,933,000.00 | ★ $6,494,748,000.00 |
| Revenue This Year | $0.01 | N/A |
| Revenue Next Year | $0.52 | $4.29 |
| P/E Ratio | ★ $27.87 | $28.96 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $54.56 |
| 52 Week High | $111.29 | $97.91 |
| Indicator | LNTH | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 31.41 |
| Support Level | $64.13 | $60.00 |
| Resistance Level | $68.84 | $64.79 |
| Average True Range (ATR) | 2.08 | 2.56 |
| MACD | 0.19 | -0.14 |
| Stochastic Oscillator | 75.19 | 31.59 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.